Tuesday, March 17, 2026

The $13.75 Billion Scam: Microsoft Is Accused of Blocking Competition To Keep AI Prices Sky-High

Microsoft faces a class-action lawsuit over alleged inflated ChatGPT fees due to an exclusive cloud contract with OpenAI.

North Korea Returns to Olympics After Eight-Year Hiatus: What to Expect in Paris 2024

Notably, North Korea will participate in the Summer Olympics for the first time in eight years.

South Korean Politician Calls for Truth and Accountability in Government

On May 14, Choo Mi Ae, who...

Tag: combination therapy

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.